Cargando…

Good multiple sclerosis (MS) care and how to get there in Canada: Perspectives of Canadian healthcare providers working with persons with MS

OBJECTIVE: The literature that has examined healthcare access and needs of the multiple sclerosis (MS) population is limited. Currently, no research has engaged healthcare providers delivering services to this population to examine their perspectives on the provision of MS care in Canada. We aimed t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Petrin, Julie, Marrie, Ruth Ann, Devonshire, Virginia, Jichici, Draga, Hrebicek, Olinka, Metz, Luanne M., Morrow, Sarah A., Oh, Jiwon, Smyth, Penelope, Donkers, Sarah J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018146/ https://www.ncbi.nlm.nih.gov/pubmed/36937527 http://dx.doi.org/10.3389/fneur.2023.1101521

Ejemplares similares

Models of Care in Multiple Sclerosis: A Survey of Canadian Health Providers
por: Marrie, Ruth Ann, et al.
Publicado: (2022)

Canadian Expert Panel Recommendations for MRI Use in MS Diagnosis and Monitoring
por: Traboulsee, Anthony, et al.
Publicado: (2015)

Prioritizing the healthcare access concerns of Canadians with MS
por: Pétrin, Julie, et al.
Publicado: (2021)

The Canadian survey of health, lifestyle and ageing with multiple sclerosis: methodology and initial results
por: Ploughman, Michelle, et al.
Publicado: (2014)

The Canadian prospective cohort study to understand progression in multiple sclerosis (CanProCo): rationale, aims, and study design
por: Oh, Jiwon, et al.
Publicado: (2021)

Recommendations for good practice in MS-based lipidomics
por: Köfeler, Harald C., et al.
Publicado: (2021)

Utilizing the 3Ms of Process Improvement
por: Morrow, Richard
Publicado: (2012)

Future MS care: a consensus statement of the MS in the 21st Century Steering Group
por: Rieckmann, Peter, et al.
Publicado: (2012)

Predictors of chronic cerebrospinal venous insufficiency procedure use among older people with multiple sclerosis: a national case–control study
por: Ploughman, Michelle, et al.
Publicado: (2015)

Utilizing the 3Ms of Process Improvement in Healthcare
por: Morrow, Richard
Publicado: (2017)

Serum neurofilament light chain in relapsing-remitting MS: Unchaining disease activity prediction?
por: Marrie, Ruth Ann
Publicado: (2017)

Charting a global research strategy for progressive MS—An international progressive MS Alliance proposal
por: Thompson, Alan J, et al.
Publicado: (2021)

Comparison of Flow Injection-MS/MS and LC-MS/MS for the Determination of Ochratoxin A
por: Zhang, Kai
Publicado: (2021)

A Comparative Analysis of Methods (LC-MS/MS, LC-MS and Rapid Test Kits) for the Determination of Diarrhetic Shellfish Toxins in Oysters, Mussels and Pipis
por: Ajani, Penelope A., et al.
Publicado: (2021)

Determination of Nine Fentanyl Drugs in Hair Samples by GC-MS/MS and LC-MS/MS
por: Wei, Qi, et al.
Publicado: (2022)

Determination of 355 Pesticides in Lemon and Lemon Juice by LC-MS/MS and GC-MS/MS
por: Aslantas, Sule, et al.
Publicado: (2023)

Posterior Reversible Encephalopathy Syndrome due to High Dose Corticosteroids for an MS Relapse
por: Morrow, Sarah A., et al.
Publicado: (2015)

Getting good reception.
Publicado: (1999)

Quantification and reporting of vitamin D concentrations measured in human milk by LC–MS/MS
por: Jones, Kerry S., et al.
Publicado: (2023)

Microsoft MS-DOS : getting started for the MS-DOS operating system versión 5.0.
Publicado: (1991)

Differing trends in the incidence of vascular comorbidity in MS and the general population
por: Marrie, Ruth Ann, et al.
Publicado: (2016)

Detecting isolated cognitive relapses in persons with MS
por: Morrow, Sarah A, et al.
Publicado: (2023)

Prioritizing progressive MS rehabilitation research: A call from the International Progressive MS Alliance
por: Zackowski, Kathleen M, et al.
Publicado: (2021)

Do the current MS clinical course descriptors need to change and if so how? A survey of the MS community
por: Thompson, Alan J, et al.
Publicado: (2023)

MALDI-TOF MS profiling approach: how much can we get from it?
por: Mehta, Angela, et al.
Publicado: (2015)

Determination of 77 Multiclass Pesticides and Their Metabolitesin Capsicum and Tomato Using GC-MS/MS and LC-MS/MS
por: Naik Rathod, Harischandra, et al.
Publicado: (2021)

Simultaneous Quantitation of Isoprenoid Pyrophosphates in Plasma and Cancer Cells Using LC-MS/MS
por: Chhonker, Yashpal S., et al.
Publicado: (2018)

Pattern II and pattern III MS are entities distinct from pattern I MS: evidence from cerebrospinal fluid analysis
por: Jarius, S., et al.
Publicado: (2017)

Differences in the burden of psychiatric comorbidity in MS vs the general population
por: Marrie, Ruth Ann, et al.
Publicado: (2015)

MS-DIAL: Data Independent MS/MS Deconvolution for Comprehensive Metabolome Analysis
por: Tsugawa, Hiroshi, et al.
Publicado: (2015)

Switching to second line MS disease-modifying therapies is associated with decreased relapse rate
por: Marriott, James John, et al.
Publicado: (2023)

Direct LC-MS/MS and indirect GC–MS/MS methods for measuring urinary bisphenol A concentrations are comparable
por: Ashley-Martin, Jillian, et al.
Publicado: (2021)

Individualised behaviour change strategies for physical activity in multiple sclerosis (IPAC-MS): protocol for a randomised controlled trial
por: Goulding, Farren L., et al.
Publicado: (2019)

Largazole Pharmacokinetics in Rats by LC-MS/MS
por: Yu, Mingming, et al.
Publicado: (2014)

Filtering of MS/MS data for peptide identification
por: Gallia, Jason, et al.
Publicado: (2013)

Application of LC–MS/MS in the Mycotoxins Studies
por: Gámiz-Gracia, Laura, et al.
Publicado: (2020)

Whatever you are, be a good one: to get from good to great, you must learn how to get good
por: Emery, Stewart, et al.
Publicado: (2010)

Selective and comprehensive analysis of organohalogen compounds by GC × GC–HRTofMS and MS/MS
por: Hashimoto, Shunji, et al.
Publicado: (2015)

LC, MS(n) and LC–MS/MS studies for the characterization of degradation products of amlodipine
por: Tiwari, Ravi N., et al.
Publicado: (2015)

Pharmacokinetic and Metabolism Studies of Curculigoside C by UPLC-MS/MS and UPLC-QTOF-MS
por: Wu, Di, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5roej7o01f8d90obb4tcse8jdg